Utility of multigene panel next‐generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer
Udit Nindra(Camden and Campbelltown Hospitals), Wei Chua(Liverpool Hospital), Abhijit Pal(Bankstown Lidcombe Hospital), Po Yee Yip(Camden and Campbelltown Hospitals), Victoria Bray, Weng Ng(Sir Run Run Shaw Hospital), Abeer Hagelamin(Liverpool Hospital), Jonathan Williamson(Liverpool Hospital), Vivienne Lea(Liverpool Hospital), C. Soon Lee(Camden and Campbelltown Hospitals), Tara L. Roberts(Camden and Campbelltown Hospitals), Therese M. Becker(Liverpool Hospital), Jingjing Li(Xuzhou Medical College), Annette Tognela(Camden and Campbelltown Hospitals), Bin Wang(Hebei Medical University), Mahtab Farzin(Liverpool Hospital)
Cited by 5
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
The mammalian PYHIN gene family: Phylogeny, evolution and expression
|BMC Evolutionary Biology|2012|202